1. Home
  2. VVPR vs COEP Comparison

VVPR vs COEP Comparison

Compare VVPR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVPR
  • COEP
  • Stock Information
  • Founded
  • VVPR 2014
  • COEP 2017
  • Country
  • VVPR United Kingdom
  • COEP United States
  • Employees
  • VVPR N/A
  • COEP N/A
  • Industry
  • VVPR Power Generation
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VVPR Utilities
  • COEP Health Care
  • Exchange
  • VVPR Nasdaq
  • COEP Nasdaq
  • Market Cap
  • VVPR 26.9M
  • COEP 32.0M
  • IPO Year
  • VVPR 2016
  • COEP N/A
  • Fundamental
  • Price
  • VVPR $6.15
  • COEP $8.95
  • Analyst Decision
  • VVPR
  • COEP
  • Analyst Count
  • VVPR 0
  • COEP 0
  • Target Price
  • VVPR N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • VVPR 1.9M
  • COEP 28.9K
  • Earning Date
  • VVPR 01-01-0001
  • COEP 05-14-2025
  • Dividend Yield
  • VVPR N/A
  • COEP N/A
  • EPS Growth
  • VVPR N/A
  • COEP N/A
  • EPS
  • VVPR N/A
  • COEP N/A
  • Revenue
  • VVPR $79,000.00
  • COEP $62,874.00
  • Revenue This Year
  • VVPR N/A
  • COEP N/A
  • Revenue Next Year
  • VVPR N/A
  • COEP N/A
  • P/E Ratio
  • VVPR N/A
  • COEP N/A
  • Revenue Growth
  • VVPR N/A
  • COEP N/A
  • 52 Week Low
  • VVPR $0.62
  • COEP $2.31
  • 52 Week High
  • VVPR $8.88
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • VVPR 60.06
  • COEP 45.20
  • Support Level
  • VVPR $4.05
  • COEP $9.14
  • Resistance Level
  • VVPR $7.15
  • COEP $9.82
  • Average True Range (ATR)
  • VVPR 1.32
  • COEP 0.54
  • MACD
  • VVPR 0.03
  • COEP -0.06
  • Stochastic Oscillator
  • VVPR 43.48
  • COEP 21.51

About VVPR VivoPower International PLC

Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: